As the eventual conclusion of Bayer’s acquisition of Monsanto draws closer, all eyes are on the German healthcare and agriculture giant to find out what the new normal will look like. In agriculture, Liam Condon, CEO of Bayer CropScience, will have the primary role in shaping that new reality.
Monsanto Growth Ventures, the venture arm of Monsanto, has lost all of its dedicated staff after former managing director John Hamer, former investment director Kiersten Stead and former principal Ryan Rakestraw all left within a month of each other.
The decision comes after weeks of votes and protests about the future of the controversial chemical in the EU, which has been far more skeptical than other parts of the world regarding glyphosate and the genetically-modified seeds created to resist it by Monsanto.
The city has companies from all over the globe relocating to take advantage of the wealth of resources at hand, but it also suffers from an exodus of companies that reach a certain point. What makes St. Louis a serious contender for the leading agtech ecosystem?
After starting in the orchards and vineyards more common to its home base, the West Coast, Ceres recently entered the row crop space largely through a partnership with Monsanto's The Climate Corporation.
The deal is also the first exit for Monsanto Growth Ventures, the agribusiness’s venture arm which has been investing since the beginning of 2013 and led the $1.2 million Series A round for VitalFields in May 2015.